On day 52 surviving mice from the HA.28ζ-GLUT1 CAR-T group were re-challenged with Nalm6-GD2 and continued to exhibit complete anti-tumor immunity for 8 days post re-challenge. The gene discussed is SLC2A1; the disease is neoplasm.